Related by context. All words. (Click for frequent words.) 77 PDE4 inhibitor 77 oral prodrug 76 phase IIb clinical 76 phase IIa clinical 76 huC# DM4 75 investigational humanized monoclonal antibody 75 liposomal formulation 75 histone deacetylase HDAC inhibitor 75 mertansine 75 BAY #-# 74 Onconase 74 proteasome inhibitor 74 Mipomersen 74 elotuzumab 74 metaglidasen 74 alvespimycin 74 Archexin 74 cannabinor 74 HCV protease inhibitor 74 Azedra 74 Carfilzomib 74 ocrelizumab 74 rNAPc2 74 Factor VIIa 73 Pimavanserin 73 JAK2 inhibitor 73 selective androgen receptor modulator 73 PRT# 73 ENMD # 73 TELINTRA 73 AEG# 73 visilizumab 73 MEK inhibitor 73 atacicept 73 L BLP# 73 HQK 73 volociximab 73 NP2 Enkephalin 73 XmAb# 73 lomitapide 73 Corlux 73 AQ4N 73 FOLOTYN ® 73 HuMax EGFr 72 receptor tyrosine kinase inhibitor 72 lumiliximab 72 Bicifadine 72 Dapagliflozin 72 pan HDAC inhibitor 72 HuMax CD4 72 JAK inhibitors 72 IMA# 72 Phase Ib clinical 72 pradefovir 72 TG# [003] 72 epothilone 72 Phase Ib study 72 synthetic retinoid 72 OHR/AVR# 72 targeted radiotherapeutic 72 virus HCV protease inhibitor 72 SUTENT ® 72 MEK inhibitors 72 Amrubicin 72 UPLYSO 72 epothilones 72 Onco TCS 72 docetaxel Taxotere R 72 pomalidomide 72 Civacir 72 PEG SN# 72 HuLuc# 72 YONDELIS 72 Traficet EN 72 TLK# 72 Xanafide 72 Phase 1b trial 72 novel oral anticoagulant 72 phase IIb 72 polymerase inhibitor 72 oral antiviral 72 glucokinase activator 72 dirucotide 72 deforolimus 71 cathepsin K inhibitor 71 GSK# [002] 71 MAGE A3 ASCI 71 selective modulator 71 AEGR 71 SARMs 71 reslizumab 71 methylnaltrexone 71 Fodosine 71 ATL# [002] 71 CDP# 71 midstage clinical 71 enzastaurin 71 phase IIa 71 intranasal formulation 71 Phase IIb clinical trials 71 preclinically 71 oral Janus kinase 71 Lixivaptan 71 obatoclax 71 Sym# 71 hypoxia activated prodrug 71 forodesine 71 Aplidin 71 neratinib 71 vascular disrupting agents 71 Panzem R NCD 71 bicifadine 71 lorvotuzumab mertansine 71 acyclovir Lauriad R 71 orally bioavailable 71 adipiplon 71 Maribavir 71 Luteinizing Hormone Releasing Hormone 71 CCR5 antagonist 71 docetaxel Taxotere ® 71 Aflibercept 71 antisense drug 71 HGS# 71 BRAF inhibitor 71 HCD# [002] 71 multicenter Phase II 71 OncoVEX GM CSF 71 GW# [003] 71 LEP ETU 71 phase IIb trial 71 HepeX B 71 humanized monoclonal 71 PrevOnco 71 ARIKACE ™ 71 diarrhea predominant irritable 71 midstage trials 71 angiogenesis inhibitor 71 ATL# [001] 71 PHX# 71 fluoroquinolone antibiotic 71 MNTX 70 RhuDex ® 70 ASONEP 70 PDX pralatrexate 70 pharmacokinetic PK study 70 Omacetaxine 70 Plicera 70 PEGylated interferon 70 HuMax CD# 70 Tyrima 70 BNC# 70 HCV protease inhibitors 70 bardoxolone 70 Onalta 70 orally administered inhibitor 70 Panzem R 70 Androxal TM 70 R#/MEM 70 AERx iDMS 70 Insegia 70 ADP receptor antagonist 70 IL# PE#QQR 70 EDEMA3 70 peripherally acting 70 Shigamabs ® 70 novel histone deacetylase 70 vidofludimus 70 selective androgen receptor modulators 70 PSN# [002] 70 Nanobody ® 70 Nexavar ® 70 teriflunomide 70 eltrombopag 70 inhaled formulation 70 Daclizumab 70 THR beta agonist 70 TBC# 70 Atrasentan 70 dalbavancin 70 OncoVex 70 cilengitide 70 axitinib 70 TACI Ig 70 dextromethorphan quinidine 70 XL# XL# 70 KRN# 70 LEUKINE 70 DU #b 70 R#/MEM # 70 PSMA ADC 70 Dalbavancin 70 RELOVAIR ™ 70 VEGF Trap 70 Anavex #-# 70 Cetrorelix 70 STEDESA 70 Dacogen injection 70 NV1FGF 70 Ridaforolimus 70 Bezielle 70 non nucleoside HCV 70 Panzem 70 Pazopanib 70 Microplasmin 70 LAF# 70 mitogen activated ERK kinase 70 Deforolimus 70 PXD# 70 evaluating tivozanib 70 atrasentan 70 sorafenib Nexavar 70 ALN PCS 70 thalidomide Thalomid 70 Phase 2a trial 70 PRTX 70 dacetuzumab 70 Clonicel 70 Octreolin 70 Phase IIIb clinical 69 riociguat 69 PKC# 69 Annamycin 69 RGB # 69 CEQ# 69 Aurora kinase inhibitor 69 Milnacipran 69 RSD# 69 Ozarelix 69 Spiegelmer ® 69 AP# [003] 69 preclinical efficacy 69 Amplimexon 69 selective adenosine 69 humanized monoclonal antibody 69 Guanilib 69 ALN TTR# 69 Squalamine 69 torezolid phosphate 69 PDE# inhibitors 69 SAR# [004] 69 Fc fusion protein 69 zanolimumab 69 sodium glucose cotransporter 69 Proxinium TM 69 confirmatory Phase III 69 GLPG# 69 Zenvia ™ 69 eprotirome 69 INCB# [002] 69 AKT inhibitor 69 Xcytrin R 69 Personalized Immunotherapy 69 DXL# 69 anticancer compound 69 Ereska 69 Tarvacin TM 69 acetonide FA 69 Liprostin 69 Dasatinib 69 Phase #/#a 69 delafloxacin 69 Zolinza 69 GRN# 69 BAL# [002] 69 sunitinib malate 69 SCH # 69 CD# monoclonal antibody 69 Phase 1b clinical 69 Friedreich Ataxia FRDA 69 LymphoStat B TM 69 ocular formulation 69 non nucleoside inhibitor 69 ATL/TV# 69 tiapamil 69 Urocidin 69 diabetic neuropathic pain 69 Octreotide 69 ulimorelin 69 Nanobody 69 INT# [002] 69 regorafenib 69 ularitide 69 cardio renal 69 Campath ® 69 Plecanatide 69 PNP inhibitor 69 KNS # 69 Phase Ib 69 tafamidis 69 Fx #A 69 Vilazodone 69 teplizumab 69 Anidulafungin 69 HDAC Inhibitor 69 fostamatinib 69 Perifosine 69 tremelimumab 69 histone deacetylase inhibitor 69 Phase Ib II 69 DEB# 69 Phase IIa clinical 69 lenalidomide Revlimid 69 tolevamer 69 Viprinex 69 TLR9 agonist 69 ProMune 69 PS# [001] 69 panitumumab Vectibix 69 tanespimycin 69 CBLC# 69 trastuzumab emtansine T DM1 69 orally dosed 69 investigational monoclonal antibody 69 Ambrisentan 69 Prodarsan ® 69 LAS# [002] 69 tasocitinib 69 PI3K/Akt pathway inhibitor 69 Aclidinium 69 Elvitegravir 69 cyclophilin inhibitor 69 tubulin inhibitor 69 tipifarnib 69 LY# [003] 69 AeroLEF TM 69 IMiDs R 69 Aurexis 69 CCR5 inhibitor 69 ganetespib 69 Cinquil 69 Eraxis 69 Silodosin 69 antibody MAb 69 Ophthotech 69 Targretin 69 SAR# [002] 69 OvaRex ® MAb 69 renin inhibitor 69 Tofacitinib 69 Vidaza azacitidine 69 NXL# 69 multi kinase inhibitor 69 otelixizumab 69 subcutaneous formulation 69 CB2 selective receptor agonist 69 Firazyr 69 INS# [001] 69 PLK1 SNALP 69 Temsirolimus 69 cetuximab Erbitux R 69 anticancer agent 69 pegylated interferons 69 teduglutide 69 vascular disrupting agent 69 Nuvion 69 humanized anti 69 proteasome inhibitors 69 trastuzumab DM1 T DM1 69 ToGA 69 MBP# [001] 69 Amigal 69 Virulizin ® 69 HIV integrase inhibitor 69 rxRNA 69 tigecycline 69 Vernakalant 69 entinostat 69 Tamibarotene 69 SPRYCEL ® 69 PEP# [003] 69 CINOD 69 AZX# 69 Tezampanel 69 superficial bladder cancer 69 selective kinase inhibitor 69 Phenoptin 69 CCX# 69 Reverset 69 gepirone ER 68 eniluracil 68 Safinamide 68 Nexavar sorafenib 68 HSP# inhibitor 68 INCB# [001] 68 Genz # 68 Aviptadil 68 Argatroban 68 Leukine ® 68 Atiprimod 68 AzaSite Plus 68 elacytarabine 68 GSK# [001] 68 Catena ® 68 Pertuzumab 68 lapatinib Tykerb 68 aurora kinase 68 Phase IIb trials 68 IAP inhibitors 68 EOquin 68 INTEGRILIN 68 nicotinic alpha 7 68 PEG Interferon lambda 68 CCR9 antagonist 68 Blinatumomab 68 IV Busulfex 68 CORT # 68 small molecule activators 68 favorable pharmacokinetic profile 68 Pruvel 68 OncoVEX 68 Rebif ® 68 Clolar ® 68 EndoTAG TM -1 68 Icatibant 68 BCR ABL inhibitors 68 investigational compound 68 Tanespimycin 68 Velcade bortezomib 68 Methylnaltrexone 68 PREOS R 68 Aganocide ® 68 Ramoplanin 68 Oral NKTR 68 bendamustine 68 chimeric monoclonal antibody 68 DDP# 68 SinuNase ™ 68 ONCONASE R 68 histamine dihydrochloride 68 Cleviprex TM clevidipine 68 BMS # 68 gefitinib Iressa 68 MGCD# [001] 68 investigational pan BCR 68 Preclinical studies suggest 68 outlicensed 68 faropenem 68 velafermin 68 E2F Decoy 68 Serdaxin 68 refractory gout 68 Zarnestra 68 ISIS # 68 class mGluR5 inhibitor 68 ibudilast 68 plasma kallikrein inhibitor 68 Diamyd ® 68 methylnaltrexone bromide 68 Phase 2a clinical 68 cediranib 68 pseudobulbar affect PBA 68 davunetide intranasal AL 68 Perforomist ™ Inhalation Solution 68 CYT# potent vascular disrupting 68 OMP #M# 68 Zenvia Phase III 68 NVA# 68 SERMs 68 tezampanel 68 Factor Xa inhibitor 68 Genentech Rituxan 68 incyclinide 68 BiTE 68 EP #R 68 GSK '# 68 mTOR inhibitor 68 trodusquemine 68 aflibercept 68 dyskinesia PD LID 68 CRD5 68 vosaroxin 68 PF # [002] 68 Plasmin 68 CD# antibody [001] 68 BEMA TM Fentanyl 68 Vicinium TM 68 afamelanotide 68 novel peptide 68 KSP inhibitor 68 NGX# 68 Phase #b/#a clinical 68 sitaxsentan 68 Granulocyte Colony Stimulating Factor 68 PROCHYMAL 68 BrachySil TM 68 therapeutic monoclonal antibody 68 HspE7 68 HuMax TAC 68 Evoltra ® 68 Valtropin 68 indibulin 68 Asentar 68 dexpramipexole 68 huN# DM1 68 Olaparib 68 amrubicin 68 maribavir 68 Phase 2b study 68 Interferon alpha 68 IMiD 68 omacetaxine 68 personalized immunotherapy 68 lesinurad 68 JAK1 68 Arcalyst 68 JAK Inhibitor 68 interferon gamma 1b 68 Aganocide 68 generation purine nucleoside 68 ketolide antibiotic 68 fosbretabulin 68 Vectibix panitumumab 68 Symadex 68 radiation sensitizer 68 posaconazole 68 MAP# 68 candidate TNFerade biologic 68 Viramidine 68 preclinical 68 XL# anticancer compounds 68 Ceflatonin 68 relapsed multiple myeloma 68 Rescula 68 Tarceva TM 68 PDE4 inhibitors 68 Indaflex TM 68 oral ridaforolimus 68 SinuNase 68 ruxolitinib 68 novel VDA molecule 68 Gattex 68 Exherin TM 68 OvaRex R 68 Elotuzumab 68 icatibant 68 VA# [002] 68 ZOLINZA 68 GA GCB 68 radezolid 68 Elagolix 68 compound INCB# 68 oral deforolimus 68 Azedra TM 68 investigational hepatitis C 68 DPX Survivac 68 Maxy G# 68 mGluR2 positive 68 Degarelix 68 Zybrestat 67 Iloperidone 67 Laquinimod 67 noninfectious uveitis 67 Aurora kinase inhibitors 67 Darusentan 67 celgosivir 67 rhFVIIa 67 HGS ETR1 67 nalbuphine ER 67 Vitaxin 67 denileukin diftitox 67 Davanat 67 Solazed TM 67 Irinotecan 67 Phase III clinical 67 Aliskiren 67 Vicriviroc 67 Phase IIb clinical 67 Phase 2b trial 67 VEGF inhibitors 67 Ocrelizumab 67 long acting muscarinic 67 TH# [003] 67 alkylating agent 67 CR# vcMMAE 67 Triolex 67 squalamine 67 Aryplase 67 antiplatelet agent 67 Levetiracetam 67 opioid induced bowel dysfunction 67 Allovectin 7 67 stable nucleic acid 67 vemurafenib 67 Lisofylline LSF 67 Acapodene 67 MKC# MKC# PP 67 Phase IIIb 67 Sebivo 67 severe gastroparesis 67 Kosan dependence 67 subcutaneously administered 67 REMINYL ® 67 Surfaxin LS 67 sorafenib tablets 67 Onalta ™ 67 Teriflunomide 67 PREOS 67 AVE# 67 MGd 67 HCV polymerase inhibitor 67 Trofex 67 Arranon 67 RECOTHROM R 67 Ophena TM 67 ADAGIO study 67 brivaracetam 67 Romidepsin 67 INCB# [003] 67 herpetic keratitis 67 Neulasta ® 67 Phase 2b clinical 67 betrixaban 67 Zoraxel 67 Cx# [002] 67 Behcet uveitis 67 isoform selective 67 Dacogen decitabine 67 mesylate 67 Relivar 67 Pradefovir 67 CD3 monoclonal antibody 67 #D#C# 67 Altastaph 67 Enzyme Replacement Therapy 67 Phase #b/#a 67 cell lymphoma CTCL 67 ceftazidime 67 rhMBL 67 Cerimon 67 PD LID 67 Neurodex 67 ELACYT 67 Hsp# Inhibitor 67 Troxatyl 67 pertuzumab 67 Debio 67 Novolimus 67 GALNS 67 Cimzia TM 67 Phase III confirmatory 67 Vidofludimus 67 PORxin TM 67 lexidronam injection 67 albinterferon alfa 2b 67 Azixa 67 renin inhibitors 67 Phase IIB 67 Cloretazine 67 #I TM# 67 Pivotal Phase III 67 Phase Ib clinical trials 67 MAXY G# 67 Afatinib 67 pharmacological chaperone 67 Myocet 67 Pancreate 67 Lu AA# 67 Phase 2a 67 Viprinex TM 67 anti CD3 antibody 67 Pagoclone 67 muraglitazar 67 Cethrin 67 selective antagonist 67 Epratuzumab 67 IMiDs ® 67 TRANSDUR Bupivacaine 67 elvucitabine 67 NeuroSTAT ® 67 oral taxane 67 phase Ib 67 targeting CD# 67 Muraglitazar 67 Desmoteplase 67 APTIVUS 67 insulin sensitizer 67 CG# [003] 67 LibiGel ® 67 EndoTAG TM 67 cancer immunotherapies 67 highly selective inhibitor 67 vinca alkaloid 67 hypoxia selective 67 Oglemilast 67 telaprevir VX 67 MyVax R 67 Actimmune ® 67 Phase 1a clinical 67 ospemifene 67 adenosine A2A 67 ZK EPO 67 Iluvien ® 67 Phase IIa trials 67 registrational 67 Ecallantide 67 TYZEKA 67 tranilast 67 oral salmon calcitonin 67 RSD# oral 67 L Annamycin 67 regadenoson 67 Hsp# inhibitor 67 vorinostat 67 Phase IIa trial 67 Humira adalimumab 67 daclizumab 67 selective estrogen receptor modulator 67 brostallicin 67 MTP inhibitor 67 Initiates Clinical 67 humanised monoclonal antibody 67 protein kinase inhibitor 67 Vivecon 67 Vascular Wrap TM 67 VEGF inhibitor 67 solithromycin 67 TKM ApoB 67 Unit Dose Budesonide 67 CIMZIA TM 67 mapatumumab 67 BioNumerik 67 Inhalation Solution 67 IGF 1R inhibitor 67 GV# [001] 67 oral JAK#/JAK# inhibitor 67 iSONEP 67 thymalfasin 67 Vascugel 67 ZACTIMA 67 Loramyc R 67 LY# [002] 67 GRN#L 67 TREANDA 67 RezularTM 67 Fibrillex TM 67 Golimumab 67 Sphingomab TM 67 NS#/#A protease 67 Ganciclovir 67 Adentri 67 Sudhir Agrawal D.Phil 67 orBec 67 XL# XL# XL# XL# 67 GLYX 67 mGluR5 NAM 67 phase IIb III 67 Varespladib 67 VAPRISOL 67 BRIM3 67 JAK3 inhibitor 67 apricitabine ATC 67 HGS ETR2 67 Revlimid lenalidomide 67 StemEx 67 DPP4 inhibitor 67 nitric oxide donating 67 octreotide implant 67 THALOMID 67 tecarfarin 67 Anticalin R 67 Gleevec imatinib mesylate 67 rilonacept 67 Kahalalide F 67 apaziquone 67 Balaglitazone 67 preclinical studies 67 erlotinib Tarceva ® 67 ponatinib 67 GED aPC 67 Zemplar Capsules 67 CYC# 67 Ceflatonin R 67 Apixaban 67 GRNVAC1 67 SinuNase TM 67 Arimoclomol 67 ALN TTR 67 anticoagulant reversing agent 67 dextofisopam 67 PEGylated Fab fragment 67 PSN# [001] 67 ELND# 67 Sphingomab 67 rituximab Rituxan 67 immunotherapeutic vaccine 67 IMiDs 67 Tasimelteon 67 OvaRex 67 Phase 2b clinical trials 67 immunotherapeutic agent 67 bortezomib Velcade 67 Akt inhibitor 67 Alinia 67 REP# 67 lixivaptan 67 belinostat 67 investigational drug 67 Gemzar ® 67 xanthine oxidase inhibitor 67 dihydrochloride 67 EDEMA4 67 Pafuramidine 66 Trastuzumab DM1 66 HDAC inhibitor 66 MOVIPREP R 66 Seliciclib 66 Exelixis compounds 66 Cellegesic 66 IAP inhibitor 66 PROMACTA 66 kinase inhibitor 66 REG1 66 AZILECT ® 66 Tesetaxel 66 IPL# 66 investigational protease inhibitor 66 immunomodulatory properties 66 ONTAK 66 selective immunoproteasome inhibitor 66 DermaVir Patch 66 LHRH antagonists 66 gamma secretase inhibitor 66 PARP inhibitor 66 Phase IIb III 66 Ixabepilone 66 systemic RNAi therapeutic 66 dose escalation Phase 66 cariprazine 66 albiglutide 66 Intravenous CP 66 Nexavar sorafenib tablets 66 Alocrest 66 Meets Primary Endpoint 66 Alzhemed TM 66 mGluR2 NAM 66 Parkinson disease levodopa induced 66 torezolid 66 Ophena 66 bioequivalency 66 GLP toxicology studies 66 XL# XL# XL# 66 Triapine 66 Initiates Phase II 66 Romiplostim 66 BCX# 66 constipation predominant irritable bowel 66 IV APAP 66 nucleotide analogue 66 danoprevir 66 5 HT6 receptor 66 erythropoietic 66 MLN# 66 Plenaxis TM 66 Enzastaurin 66 ORENCIA R 66 induced macular edema 66 Diamyd R 66 Cethrin R 66 budesonide foam 66 Nanobodies 66 Ticagrelor 66 Solazed ™ 66 PANVAC VF 66 INSPIRE Trial Phase III 66 beta interferons 66 Valdoxan 66 initiated Phase Ib 66 PEGylated 66 CA4P 66 2 methoxyestradiol 66 Benlysta belimumab 66 R sorafenib tablets 66 custirsen 66 elinogrel 66 injectable formulation 66 myeloproliferative disorders 66 OMNARIS HFA 66 selective S#P# receptor agonist 66 OXi# 66 urocortin 2 66 Olmesartan 66 CB1 antagonists 66 histone deacetylase HDAC 66 Pathway Inhibitor 66 epigenetic therapies 66 pain palliation 66 Sapacitabine 66 Apoptone 66 midstage studies 66 NNR Therapeutics 66 Abbokinase 66 Eltrombopag 66 phase Ib clinical 66 rasagiline tablets 66 romidepsin 66 alemtuzumab Campath 66 ANG# 66 photoprotective drug 66 AAG geldanamycin analog 66 beta 1a 66 BRIM2 66 rhThrombin 66 Telatinib 66 PRX # 66 TLR9 agonists 66 ACV1 66 Epirubicin 66 etanercept Enbrel 66 Valsartan 66 SNT MC# 66 TRISENOX 66 PI3K inhibitor 66 Trandolapril 66 EOquin TM 66 Vaprisol 66 oxymorphone ER 66 adenosine injection 66 Prednisporin TM 66 erlotinib Tarceva 66 nitric oxide donating prostaglandin 66 tamibarotene 66 Soliris eculizumab 66 TRO# 66 TOCOSOL Paclitaxel 66 Aurora Kinase 66 Prosaptide 66 DOS# 66 Cethromycin 66 Saforis 66 Nanobody R 66 bevasiranib 66 olaparib 66 Crofelemer 66 oral Factor Xa 66 Albugon 66 interleukin IL -# 66 RhuDex 66 acyclovir Lauriad ® 66 terlipressin 66 LEVADEX ™ 66 Aurograb 66 valopicitabine 66 casopitant 66 Chrysalin 66 candidate CRLX# 66 RG# [001] 66 EndoTAGTM 1 66 KIACTA ™ 66 beta2 agonist 66 phase III isavuconazole 66 RG# ITMN 66 targeted antifolate 66 balsalazide tablet 66 AVONEX ® 66 angiotensin receptor blocker ARB 66 humanized antibody 66 Erbitux cetuximab 66 adrenergic regulation 66 fipamezole 66 Pemetrexed 66 mipomersen 66 G#DT 66 Pegloticase 66 Initiate Phase 66 Cancidas 66 Rasagiline 66 pharmacokinetic interactions 66 GMX# 66 Phase IIb 66 TRISENOX ® 66 relapsing multiple sclerosis 66 Oracea TM 66 sodium glucose transporter 66 generation proteasome inhibitor 66 defensin mimetic antibiotic 66 IMC A# 66 Panzem ® 66 systemically administered 66 cangrelor 66 Busulfex 66 oral JAK1 66 HGS ETR1 mapatumumab 66 Copegus ribavirin 66 cMET inhibitor 66 relapsed MM 66 CANCIDAS 66 Atu# 66 ceftaroline 66 nucleoside analog 66 canakinumab 66 Zalypsis 66 integrase inhibitor 66 Proellex TM 66 PF # [001] 66 Anturol ® 66 Certolizumab pegol 66 Allovectin 7 R 66 myelofibrosis polycythemia vera 66 Lenocta